Literature DB >> 22238444

Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.

Anna Kaltsas1, Matt Simon, Larissa H Unruh, Crystal Son, Danielle Wroblewski, Kimberlee A Musser, Kent Sepkowitz, N Esther Babady, Mini Kamboj.   

Abstract

The aim of this study was to compare the clinical and laboratory characteristics of Clostridium difficile infection (CDI) in patients with discordant test results for the cytotoxin assay (CYT) and PCR assays. A retrospective study from May to August 2008 and March to May 2010 was performed. CDI was diagnosed in 128 patients. PCR increased the yield of C. difficile cases by 2-fold compared to that of the CYT assay. Fifty-six cases (44%) were detected by PCR only (CYT negative). Forty-nine percent of patients with non-NAP1 strains were detected by PCR only, compared to 28% of those infected with NAP1 strains (P < 0.05). No significant differences were found in the clinical severity of illness and outcome among patients that tested positive for CDI by both tests (CYT and PCR) compared to those that tested positive by PCR only.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238444      PMCID: PMC3318505          DOI: 10.1128/JCM.05711-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Retrospective studies and chart reviews.

Authors:  Dean R Hess
Journal:  Respir Care       Date:  2004-10       Impact factor: 2.258

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Authors:  Fred C Tenover; Susan Novak-Weekley; Christopher W Woods; Lance R Peterson; Thomas Davis; Paul Schreckenberger; Ferric C Fang; Andre Dascal; Dale N Gerding; Jim H Nomura; Richard V Goering; Thomas Akerlund; Alice S Weissfeld; Ellen Jo Baron; Edith Wong; Elizabeth M Marlowe; Joseph Whitmore; David H Persing
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

4.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

5.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

6.  Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.

Authors:  N Esther Babady; Jeffrey Stiles; Phyllis Ruggiero; Perminder Khosa; David Huang; Susan Shuptar; Mini Kamboj; Timothy E Kiehn
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 7.  The challenges posed by reemerging Clostridium difficile infection.

Authors:  David B Blossom; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2007-06-04       Impact factor: 9.079

8.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

Authors:  Annie-Claude Labbé; Louise Poirier; Duncan Maccannell; Thomas Louie; Michel Savoie; Claire Béliveau; Michel Laverdière; Jacques Pépin
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

10.  Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.

Authors:  Lynne M Sloan; Brian J Duresko; Daniel R Gustafson; Jon E Rosenblatt
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

View more
  30 in total

1.  Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.

Authors:  Thais Simões Camargo; Moacyr Silva Junior; Luis Fernando Aranha Camargo; Veronica Pivetta Biotto; André Mario Doi; Paula Celia Mariko Koga; Carolina Nunes França; Marines Dalla Valle Martino
Journal:  Arch Microbiol       Date:  2021-01-18       Impact factor: 2.552

2.  Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.

Authors:  Fiona Senchyna; Rajiv L Gaur; Saurabh Gombar; Cynthia Y Truong; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

3.  Reply to Planche et al.

Authors:  Krishna Rao; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2015-06-19       Impact factor: 9.079

4.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

5.  Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yeon Joo Lee; Esther S Arguello; Robert R Jenq; Eric Littmann; Grace J Kim; Liza C Miller; Lilan Ling; Cesar Figueroa; Elizabeth Robilotti; Miguel-Angel Perales; Juliet N Barker; Sergio Giralt; Marcel R M van den Brink; Eric G Pamer; Ying Taur
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

6.  Clostridium difficile testing: have we got it right?

Authors:  Wei-Yuen Su; Joanne Mercer; Sebastiaan J Van Hal; Michael Maley
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

7.  Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Authors:  J L Leslie; S H Cohen; J V Solnick; C R Polage
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 3.267

Review 8.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

9.  Molecular-based diagnosis of Clostridium difficile infection is associated with reduced mortality.

Authors:  Tomer Avni; Tanya Babich; Haim Ben-Zvi; Alaa Atamna; Dafna Yahav; Daniel Shepshelovich; Yaara Leibovici-Weissman; Jihad Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-07       Impact factor: 3.267

10.  Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report.

Authors:  Mini Kamboj; Crystal Son; Sherry Cantu; Roy F Chemaly; Jeanne Dickman; Erik Dubberke; Lisa Engles; Theresa Lafferty; Gale Liddell; Mary Ellen Lesperance; Julie E Mangino; Stacy Martin; Jennie Mayfield; Sapna A Mehta; Susan O'Rourke; Cheryl S Perego; Randy Taplitz; Janet Eagan; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2012-09-24       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.